Trial intelligence / Profile preview

Pentaxim and CYD Dengue Vaccine Concomitant Administration in Toddlers

NCT01411241Phase 3Completed

Sponsor
Sanofi
Start
Jul 2011
Primary completion
Feb 2014
Countries
1
01

Overview

A Phase 3 trial of CYD-TDV in dengue fever, sponsored by Sanofi. Started Jul 2011; status: completed.

02

Drugs

CYD-TDV
03

Conditions

dengue fever

Beyond the preview

Go deeper on NCT01411241.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01411241.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call